KALV
KalVista Pharmaceuticals, Inc. · Healthcare
Chief Development Officer Christopher Yea sold $30K of KalVista Pharmaceuticals, Inc.
Sold$29,650
$26.76Price
1,108Shares
What KALV did after the filing
- The stock from Wed, May 20 open, $26.77
- +0.1%
- S&P 500, same days
- +2.0%
3 of 30 trading days so far, to the May 26 close.
Traded Mon, May 18. Filed Tue, May 19, 4:05 PM ET, after the close. Returns use the May 20 open and the May 26 close. Not investment advice.